Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Feb 22, 2022
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Karyopharm Therapeutics Inc.
| -1.31K |
$12.12 | -$15,833.16 | -1.00% | 129.45K | +1 |
Feb 17
| ||||||
Karyopharm Therapeutics Inc.
| -1.70K |
$9.86 | -$16,804.85 | -1.29% | 130.76K | +1 |
Feb 7
| ||||||
Karyopharm Therapeutics Inc.
| -665.00 |
$9.73 | -$6,470.45 | -0.50% | 131.14K | +1 |
Jul 12
| ||||||
Karyopharm Therapeutics Inc.
| 23.25K |
$8.60 | $199,991.85 | +21.42% | 131.8K | +1 |
May 7
| ||||||
Karyopharm Therapeutics Inc.
| 22.01K |
—
|
—
| +25.69% | 107.69K | +1 |
Feb 25
| ||||||
Karyopharm Therapeutics Inc.
| -1.19K |
$14.83 | -$17,589.80 | -2.24% | 51.79K | +1 |
Feb 18
| ||||||
Karyopharm Therapeutics Inc.
| 3.1K |
$15.52 | -$27,127.39 | +6.22% | 52.98K | +1 |
Feb 11 - Feb 15
| ||||||
Karyopharm Therapeutics Inc.
| 5.65K |
—
|
—
| +12.78% | 49.88K | +1 |
Feb 5
| ||||||
Karyopharm Therapeutics Inc.
| 1.82K |
$19.46 | -$11,461.94 | +2.16% | 86.4K | +1 |
Jul 11 - Jul 15
| ||||||
Karyopharm Therapeutics Inc.
| -1.38K |
$16.48 | -$22,662.61 | -3.26% | 40.76K | +1 |
Feb 19
| ||||||
Karyopharm Therapeutics Inc.
| 4.85K |
—
|
—
| +13.01% | 42.13K | +1 |
Feb 15
| ||||||
Karyopharm Therapeutics Inc.
|
0
|
—
|
—
|
—
|
0
| +1 |
Feb 5
| ||||||
Karyopharm Therapeutics Inc.
|
0
|
—
|
—
|
—
|
0
| +1 |
Jul 11
| ||||||
Karyopharm Therapeutics Inc.
|
0
|
—
|
—
|
—
|
0
| +1 | |||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. |